News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Clinical Study Finds BioE, Inc. (Formally known as BioErgonomics)'s PrepaCyte-CB Significantly Improves Cell Recoveries from Cord Blood


5/9/2007 1:14:04 PM

ST. PAUL, Minn.--(BUSINESS WIRE)--BioE®, Inc., a biomedical company that provides enabling, high-quality human stem cells for drug discovery and therapeutic research, announced today its PrepaCyte®-CB Umbilical Cord Blood Processing System significantly improves the recovery of therapeutically important total nucleated cells (TNC) and white blood cells (WBC) from human umbilical cord blood when compared to traditional hetastarch-based cord blood processing methods, according to the results of a multi-site, comparative, in-vitro clinical study.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES